RxDoctor Payments DataLook up a doctor →

William Lombardi, MD

Interventional Cardiology · Seattle, WANPI 1942250717

Payments from drug & device makers

$1,213,188in general payments, 2019–2025

Across 525 payments — averaging $2310.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Asahi Intecc CO., LTD.$274K
  • Corindus Inc.$239K
  • Seigla Medical, Inc.$200K
  • Asahi Intecc USA, Inc.$151K
  • Boston Scientific$95K
  • Siemens Medical Solutions USA, Inc.$88K
  • plus $167K from 21 others

What the payments were for

  • Royalty or licence$402,35945%
  • Consulting fees$49,9706%
  • Speaking & faculty fees$143,22516%
  • Travel & lodging$45,9575%
  • Food & beverage$25,5673%
  • Ownership interest$234,60926%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,213,188 in reported general payments places this provider in the 95th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$96,818
Medicare patients
135
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →